News | March 16, 2026
QIAGEN bags FDA nod for full GI testing on QIAstat-Dx Rise system
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Germany will be the first launch market
ShunzymeX leverages a proprietary protease to streamline purification
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
The new service delivers end-to-end support, managing every stage of an epigenomics project
Fid?s brings core strengths across imaging applications and human biology, supporting work in digestive disease, GI oncology, and select solid tumors
Subscribe To Our Newsletter & Stay Updated
